Inhaled and systemic steroid exposure and neurodevelopmental outcome of preterm neonates

References

• Jensen EA, Schmidt B. Epidemiology of bronchopulmonary dysplasia. Birth Defects Res A Clin Mol Teratol. 2014;100(3):145–157.
   PubMed Web of Science ®Google Scholar
• Strueby L, Thébaud B. Advances in bronchopulmonary dysplasia. Expert Rev Respir Med. 2014;8(3):327–338.
   PubMed Web of Science ®Google Scholar
• Natarajan G, Pappas A, Shankaran S, et al. Outcomes of extremely low birth weight infants with bronchopulmonary dysplasia: impact of the physiologic definition. Early Hum Dev. 2012;88(7):509–515.
   PubMed Web of Science ®Google Scholar
• American Academy of Pediatrics, Committee on Fetus and Newborn, Canadian Paediatric Society, Fetus and Newborn Committee. Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants. Pediatrics. 2002;109(2):330–338.
   PubMed Web of Science ®Google Scholar
• Onland W, Offringa M, De Jaegere AP, et al. Finding the optimal postnatal dexamethasone regimen for preterm infants at risk of bronchopulmonary dysplasia: a systematic review of placebo-controlled trials. Pediatrics. 2009;123(1):367–377.
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Committee on Fetus and Newborn, American Academy of Pediatrics. Committee on Fetus and Newborn. Policy statement—Postnatal corticosteroids to prevent or treat bronchopulmonary dysplasia. Pediatrics. 2010;126(4):800–808.
   PubMed Web of Science ®Google Scholar
• Bassler D, Plavka R, Shinwell ES, et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N Engl J Med. 2015;373(16):1497–1506.
   PubMed Web of Science ®Google Scholar
• Shinwell ES, Portnov I, Meerpohl JJ, et al. Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis. Pediatrics. 2016;138(6).
   PubMed Web of Science ®Google Scholar
• Nakamura T, Yonemoto N, Nakayama M, et al. Arch Dis Child Fetal Neonatal Ed. 2016;101:F552–556.
   Google Scholar
• Cole CH, Colton T, Shah BL, et al. Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia. N Engl J Med. 1999;340(13):1005–1010.
   PubMed Web of Science ®Google Scholar
• The Canadian Neonatal Network. The Canadian Neonatal abstractor’s Manual v. March 16, 2016; [cited 2016 October 31]. Available from: http://www.canadianneonatalnetwork.org/Portal/LinkClick.aspx?fileticket=zrcLU_ttnkk%3d&tabid =69.
   Google Scholar
• The Canadian Neonatal Follow-up Network. 18-month corrected age assessment manual version 5; September 2012; [cited 2016 October 31]. Available from: http://www.cnfun.ca/LinkClick.aspx?fileticket=d4p7mZoXWDU%3d&tabid =68.
   Google Scholar
• Richardson DK, Corcoran JD, Escobar GJ, et al. SNAP-II and SNAPPE-II: simplified newborn illness severity and mortality risk scores. J Pediatr. 2001;138(1):92–100.
   PubMed Web of Science ®Google Scholar
• Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978;187(1):1–7.
   PubMed Web of Science ®Google Scholar
• Shennan AT, Dunn MS, Ohlsson A, et al. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988;82(4):527–532.
   PubMed Web of Science ®Google Scholar
• International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123(7):991–999.
   PubMed Web of Science ®Google Scholar
• Papile LA, Burstein J, Burstein R, et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529–534.
   PubMed Web of Science ®Google Scholar
• Bayley N. Bayley scales of infant and toddler Development®. third ed (Bayley-III®), Toronto (ON): Pearson Corporation Pearson Canada; 2005.
   Google Scholar
• Palisano R, Rosenbaum P, Walter S, et al. Development and reliability of a system to classify gross motor function in children with cerebral palsy. Dev Med Child Neurol. 1997;39(4):214–223.
   PubMed Web of Science ®Google Scholar
• Wilson-Costello D, Walsh MC, Langer JC, et al. Neonatal Research Network. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months’ adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics. 2009;123(3):e430–e437.
   PubMed Web of Science ®Google Scholar
• O’Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebo-controlled trial of a 42 day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104(1 Pt 1):15–21.
   PubMed Web of Science ®Google Scholar
• Cummings JJ, D’Eugenio DB, Gross SJ. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320(23):1505–1510.
   PubMed Web of Science ®Google Scholar
• Doyle LW, Ehrenkranz RA, Halliday HL. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2014;5(5):CD001146.
   Google Scholar
• Doyle LW, Ehrenkranz RA, Halliday HL. Late (> 7 days) postnatal corticosteroids for chronic lung disease in preterm infants. Cochrane Database Syst Rev. 2014;5(5):CD001145.
   Google Scholar
• Malaeb SN, Stonestreet BS. Steroids and injury to the developing brain: net harm or net benefit? Clin Perinatol. 2014;41(1):191–208.
   PubMed Web of Science ®Google Scholar
• Chang YP. Evidence for adverse effect of perinatal glucocorticoid use on the developing brain. Korean J Pediatr. 2014;57(3):101–109.
   PubMedGoogle Scholar
• Parikh NA, Lasky RE, Kennedy KA, et al. Postnatal dexamethasone therapy and cerebral tissue volumes in extremely low birth weight infants. Pediatrics. 2007;119(2):265–272.
   PubMed Web of Science ®Google Scholar
• Cole CH, Shah B, Abbasi S, et al. Adrenal function in premature infants during inhaled beclomethasone therapy. J Pediatr. 1999;135(1):65–70.
   PubMed Web of Science ®Google Scholar
• Renault A, Patkaï J, Dassieu G, et al. Hydrocortisone use in ventilated extremely preterm infants decreased bronchopulmonary dysplasia with no effects on neurodevelopment after two years. Acta Paediatr. 2016;105(9):1047–1055.
   PubMed Web of Science ®Google Scholar
• Baud O, Trousson C, Biran V, et al. Association between early low-dose hydrocortisone therapy in extremely preterm neonates and neurodevelopmental outcomes at 2 years of age. JAMA. 2017;317(13):1329–1337.
   PubMed Web of Science ®Google Scholar